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ABSTRACT
Proteolytic Activity of Some Milk-Clotting Enzymes on
K-casein and K-casein Macropeptide
by
Khalid M. Shammet, Doctor of Philosophy
Utah State University, 1989
Major Professor: Dr. Rodney J. Brown
Department: Nutrition and Food Sciences
This work reviews studies of bovine K-casein and specifically K-casein macropeptide.
Properties of K-casein, its structure and heterogeneity, proteolytic activity of some milk
clotting enzymes on K-casein, and K-casein sensitive bonds are discussed. Macropeptides
of other species are also presented. The carbohydrate moieties of bovine macropeptide
together with their biological and physiological functions are reviewed .
Macropeptides were produced by enzymic hydrolysis from whole casein solution
using crystalline chymosin (EC 3.4.23.4). Trichloroacetic acid (final concentrations 2, 8
and 12%) was added after 5, 30 and 60 min of incubation to precipitate protein and
inactivate the enzyme. The filtrate was then exhaustively dialyzed against distilled water
to remove trichloroacetic acid and small molecules. The dialyzate was lyophilized and
stored at -2o·c until required for analysis. These macropeptides were then compared
using RP-HPLC with macropeptides obtained from purified K-casein isolates by the same
method (15 min incubation).
Proteolytic activity of some milk-clotting enzymes (chymosin, Mucor miehei rennet
and Endothia parasitica rennet) and some proteinases (trypsin and chymotrypsin) on
K-casein and macropeptide isolated from K-casein was followed by RP-HPLC. The
milk-clotting enzymes were standardized to the same clotting activity using a Formagraph.

xi

Each enzyme was incubated with .5 mix-casein and macropeptide solutions ( 10 mg in
1 ml .05 MpH 6.6 phosphate buffer) at 3TC for various incubation times. Reactions
were stopped by addition .5 ml of 8 Murea containing I0-5 Mpepstatin or .025 ml
pepstatin ( 1 mg pepstatin in 1 ml methanol). These reaction mixtures were separated into
fractions using RP-HPLC and chromatograms of the different enzymes compared.
(138 pages)

GENERAL INTRODUCTION
Chymosin (EC 3.4.23.4) preferentially splits K-casein between amino acid residues
105 and 106. This leads to formation of insoluble para-1<-casein (residues 1-105). The
macropeptide (MP) (residues 106-169) remains soluble in water. When K-casein contains
carbohydrate, the later peptide is referred to as glycomacropeptide (GMP). MP can be
separated readily from para-1<-casein by virtue of its solubility in trichloroacetic acid
(TCA). However, MP is heterogeneous and consists of a series of components with
varying carbohydrate composition and consequently varying solubility in TCA solution.
The heterogeneity of K-casein is found in the MP.
MP has been used to study problems in the dairy industry, such as heat stability of
milk and milk coagulation. It has many biological and physiological functions. It
stimulates calf abomasum cells producing chymosin and is effective as a bifidus growthpromoting factor. When MP is injected into dogs, it inhibits their gastric secretion.
The aims of this study were to:
• Compare TCA fractionation methods for isolating the macropeptide fraction
from casein using reverse phase high performance liquid chromatography
(RP-HPLC) and to isolate a homogeneous variant ofmacropeptide from
1<-casein.
• Follow and compare proteolytic activity of different concentrations of some
milk-clotting enzymes (chymosin, Endothia parasitica rennet, and Mucor
mieheirennet) on 1<-casein, at pH 6.6 and 3TC.
• Investigate resistance of macropeptide to some milk-clotting enzymes such as
chymosin, bovine pepsin, E. parasitica rennet, and M. miehei rennet, and to
some gastric proteinases (trypsin and chymotrypsin).
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PART 1: K-CASEIN AND K-CASEIN MACROPEPTIDE: A REVIEW
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ABSTRACT
This work reviews studies of bovine K-casein and specifically K-casein macropeptide .
Properties of K-casein, its structure and heterogeneity, proteolytic activity of some milk
clotting enzymes on K-casein, and K-casein sensitive bonds are discussed. Macropeptides
of other species are also presented. The carbohydrate moieties of bovine macropeptide
together with their biological and physiological functions are reviewed.

K-CASEIN
K-casein History
Alais et al. (2) reported in 1953, the rapid release of peptide material (equal to 5% of
the casein nitrogen) from whole casein when it is transformed into para-casein by calf
rennet at the pH of normal milk. In 1956, Waugh and Von Hippel (80) first identified and
isolated a component of a-casein complex equal to about 15% of the total which they
called K-casein. They concluded that stability of casein micelles in milk is due to the action
of K-casein which protects whole casein micelles against flocculation by calcium ions.
The peptide freed during attack by calf rennet on casein originates from this fraction (78 ).
In 1957, Wissmann and Nitschmann (82) treated a-casein with calf rennet and
observed the appearance of Phe as a new N -terminal residue in a-casein. This led to the
conclusion that the primary action of calf rennet is a specific and limited hydrolysis of
K-casein even though, in 1959, Wake (78) found no difference between theN-terminal
residue of K-casein before and after treatment with calf rennet, and had concluded that no
peptide bonds were split. Beeby (10) suggested that K-casein is not a single protein but
a complex and that the action of the calf rennet is first to open the secondary bonds
responsible for the stability of the complex.
The primary structure of bovine K-casein was determined by Mercier et al. ( 45) . It is
made up of a single polypeptide chain containing 169 amino acid residues: 4 Asp, 7 Asn,

4
14 Thr, 12 Ser, 1 SerP, 1 ProGlu, 12 Glu, 14 Gin, 20 Pro, 2 Gly, 15 Ala, 11 Val, 2
1f2Cys, 2 Met, 13 Ile, 8 Leu, 9 Tyr, 4 Phe, 9 Lys, 3 His, 1 Trp, 5 Arg, with
NH2-terminal ProGlu (44). There are two genetic variants ofl<:-casein. The B variant
differs from A variant by substitution ofThr for Ile in position 136 and Asp for Ala in
position 148 (44, 45). Seibert et al. (59) recently, detected a third variant ofx-casein in
German Simmental cattle. Using isoelectric focusing, it forms a band located between
1<-casein A and B. It is named 1<-casein D and cannot be distinguished from x-casein A
using either polyacrylamide or starch gel electrophoresis.
x-casein has a high content (11.8%) and uniform distribution of Pro that limits any
a-helical structure. Other hydrophobic and charged amino acid residues are distributed
non-uniformly along the peptide chain. Most of the acidic residues are located at the
N-and C-terminal ends of the molecule while most of the basic amino acid residues are
distributed uniformly in the para-1<-casein section. This also contains numerous
hydrophobic residues, all the aromatic residues of 1<-casein and its two Cys residues (45).
x-casein is unique among all proteins because of its carbohydrate content. Milk
contains 3.3 grnlkg of 1<-casein (79). Based on its amino acid sequence, a carbohydratefree monomer of 1<-casein B has a molecular weight of 19,023 daltons. It contains one
phosphate group at Ser149 and sometimes another one at Ser127 (7 6, 79). 1<-casein
contains .3% phosphate, 15.4% nitrogen, 1.6% ash and 1.9% sialic acid. Its isoelectric
point is at pH 3. 7, and its isoionic point is at pH 5.1. Its average hydrophobicity is 1,285
cal (5.37 kJ) per residue; it has a net charge at pH 6.8 of 3.5 for the monomeric 1<-casein
devoid of sialic acid (44); and it has a molar extinction coefficient at 278 nm of 1.22 (44,
45, 79).
Vreeman et al. (76) demonstrated that in aqueous solution 1<-casein forms globular
micelles composed of 30 subunits. The radius of these spherical micelles is 11-23 nm
(12), and they have a molecular weight of 5. 7 x 105 daltons (30 monomers). They are
formed by covalent S-S linkages between the 1<-casein molecules with a ~Gassociation of -
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36 kJ/mole K-casein ( 64 ). ](-casein binds about two ea2+ ions per molecule at neutral pH
but differs markedly from other caseins in its solubility over a wider ea2+ concentration
range (79).
In comparison, the molecular weight of human 1<-casein is about 38,000. This
difference in total molecular weight between bovine and human K-casein is due to the
different amounts of carbohydrates they contain (7).
Heterogeneity of lC-casein
With the exception ofK-casein, all the components of whole casein are resolved into
sharp bands when analyzed by starch electrophoresis. Gel electrophoresis of K-casein
reveals the presence of seven to eight discrete bands (39, 41). These bands are degraded
by chymosin (EC 3.4.23.4) , leading to the conclusion that they are related (41).
Furthermore, when K-casein is attacked by chymosin it yields only one major and one
minor derivative ofpara-1<-casein. However, the macropeptide (MP) portion ofK-casein,
released by chymosin hydrolysis, can be separated into at least three well-defined
components which all have similar amino acid residues (18, 45). Both variants of
K-casein yield similar patterns of heterogeneity. Bovine 1<-casein A has been fractionated
into nine components on DEAE-cellulose, all of which were identified asK-casein from
immunological analysis (64).
The general picture that emerges is that K-casein is discretely heterogeneous. It
consists of two major and about five minor components. These components are
crosslinked by oxidation of SH groups to give intermolecular S-S bonds (39). This
heterogeneity of 1<-casein is responsible for the spreading of 1<-casein in electrophoretic
patterns (39, 41, 64). When the S-S bonds inK-casein are broken by 2-mercaptoethanol,
1<-casein can then be resolved into a number of discrete bands in starch gels. These
represent the smaller 1<-casein units previously held together by S-S bridges (45, 64).
Because of the molecular sieving effect of the gel, K-casein moves more slowly than its
derivatives. Occasionally K-casein has been observed to form bands probably resulting
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from a partial rupture of S-S bonds during analysis.
As a glycoprotein, bovine K-casein is also heterogeneous because of its carbohydrate
content (39, 41). This can be attributed to genetic polymorphism and to variations in
extent of post-translational glycosylation that occurs (1). Since the carbohydrate of
K-casein is contained in the MP, it also gives a pattern of heterogeneity similar to that in
K-casein (41) . Most of the variation inK-casein is in the MP because apart from variations
in carbohydrate content the amino acid substitutions which distinguish type A and B
K-casein also occur in the MP region (6, 30). Phosphate content may also contribute to
heterogeneity (64) .
K-casein contains 0-4 moles ofN-acetylgalactosamine (GalNAc)/mole K-casein and
0-8 moles ofN-acetylneuraminic acid (NeuAc)/mole K-casein (45 , 65). Its heterogeneit y
is explained by step wise increase in carbohydrate content. Also, no other protein accepts
GalNAc (65) . The micelle-stabilizing ability ofK-casein subcomponents increases with
their carbohydrate content ( 64 ). It may be that heterogeneity of the carbohydrate plays a
role in furnishing protection against natural proteases present in milk.
Proteolytic Activity Toward Casein
Fractions of Some Milk-Clotting Enzymes
Milk-clotting enzymes suitable for cheese making should combine high specific
cleavage activity towards K-casein, at the pH of the milk, with low general proteolytic
activity under cheese-ripening conditions. In several studies, clotting to proteolytic
activity ratio has been used to distinguish enzymes for their suitability as milk-clotting
agents (73). Chymosin is ideal for cheese production because of its limited general
proteolytic activity on K-casein and its high ratio of clotting activity to general proteolytic
activity (73). At normal milk pH, chymosin cleaves the (Phe10s-Met106) peptide bond of
K-casein. Yielding para-K-casein (residues 1 to 105) and MP (residues 106 to 169). In
K-casein containing carbohydrate, the later peptide is called glycomacropeptide (GMP).
Much research has been conducted to elucidate the action of several clotting enzymes
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on 1<-casein (1, 2, 6, 10, 18, 22, 29, 35, 36, 38, 66, 73). El Negoumy (22) detected at
least eleven break-down products of 1<-casein, most of which are negatively charged.
Moreover, 1<-casein is the only component of whole casein attacked by chymosin within
50 min, yielding several slow and fast moving components. Itoh and Thomasow (29)
studied the action of calf rennet and other milk-clotting enzymes on casein fractions. They
reported that all enzymes produce non-protein nitrogen (NPN) from 1<-casein after 5 min
of incubation due to liberation ofMP. Liberation ofNPN by chymosin and bovine pepsin
is stabilized after 10 min of incubation, while NPN liberation by the Mucor pusillus
enzyme continues through 60 min. The action of Bacillus polymyxa protease on 1<-casein
shows no limitation. 1<-casein is degraded to para-1<-casein when treated with the enzyme
for 5 min. This indicates that all enzymes have the same specific proteolytic action on
1<-casein at the beginning of the reaction. At the end of the reaction, para-1<-caseins
produced are not identical for all milk-clotting enzymes (38).
Tam and Whitaker ( 66) studied hydrolysis of several caseins using bovine pepsin,
chymosin, Endothia parasitica and M. pusillus rennets. They found that at pH 6.0 all four
enzymes have the fastest initial rate of hydrolysis on 1<-casein. E. parasitica rennet has
more activity than the other three enzymes on all substrates at all pH's values. E.

parasitica rennet shows relatively high proteolytic activity on whole caseins and as- and
1<-casein components. Whereas, Mucor miehei rennet has more moderate activity; its
action modality is close to that of chymosin, but still it is not specific for 1<-casein (52). At
pH 6.0, Kovacs-Proszt and Sanner (36) investigated the specificity and kinetic properties
of three milk-clotting enzymes. They suggested that the Km value for aggregation of
1<-casein by the microbial enzymes is about 100 times smaller than Km for the proteolytic
activity of calf chymosin on K-casein.
Rate and extent of NPN formation from whole casein is higher with microbial rennets
than with chymosin (68). Breakdown of 1<-casein is achieved by both enzymes within the
first 5 min of the reaction. However, during the following period strong deviations are
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found in the action of the two enzymes, apparently owing to the higher non-specific
proteolytic activity of microbial rennets. With chymosin the reaction stops after 10 to

15 min, while with microbial rennets NPN-formation increases up to 60 min. NPN
formed by chymosin during 1 h of incubation is 5.1% while microbial rennets release

8.3% (68).
Recently, Kobayashi et al. (35) studied the specificity of the milk-clotting enzyme
from Iprex /acteus on 1<-casein. They reported that I. Jacteus enzyme hydrolyzes the bond
Phe 105 -Metl06 ofK-casein, and the positions Leu79-Sergo and Tyr 30 -Val 31 of
para-1<-casein. They also mentioned that it is not clear how this enzyme acts on the MP
fraction of 1<-casein.
K-casein Sensitive Bond (Phe IOs-Metio6)
Jolles et al. (30) reported that the clotting of milk for cheese making is initiated by
specific enzyme cleavage of the sensitive Phe10s-Met106 peptide bond ofK-casein, which
results in removing a hydrophilic MP 106-169 part of K-casein.
Delfour et al. (19) found a Met residue followed by Ala at theN-terminal end ofMP.
This finding strongly favored the existence inK-casein of a chymosin sensitive peptide
bond , Phe10s-Met1o6· Hill et al. (26) found the same C-terminal sequence, Leu-SerPheOH, on both para-1<-casein components, indicating that chymosin splits a single
peptide linkage in 1<-casein. In 1968, Jolles et al. (30) isolated a peptide comprising the C
and N-terminal fragments of para-K-casein and MP from a tryptic digest of 1<-casein. This
was the proof that chymosin splits a Phe10s-Met1o6 bond inK-casein. Phe10s-Met1o6 is
extremely liable to chemical, physical and enzymic attack since it is exposed to solvent and
in a loose configuration.
Several studies have been conducted to explain the specificity ofPhe10s-Met1o6 bond
to chymosin using synthetic peptide substrate (56, 57, 73, 74, 75). The minimum
requi rement for getting at least some substrate activity is a chain length of five amino acid
residues having Phe10s-Met1o6 as a non-terminal unit. Peptides having extended chain but
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missing Leu103 or Ile1os residues are poor substrates (74). This emphasizes the
significance of secondary binding sites on both sides of the susceptible Phe1os-Met106
bond (45, 73). The segment His9s-Pro99-His1oo-Prolo1-His1o2 and segment IleiosProlo9-ProllO are required to make the whole K-casein molecule sensitive to cleavage by
chymosin near neutral pH. The hydroxyl function ofSeq04 is strongly involved,
probably via hydrogen bond formation, in the interacting enzyme-substrate system (73).

1e-CASEIN MACROPEPTIDE
At neutral pH, chymosin rapidly cleaves a specific peptide bond (Phe 1os-Met1o6) in
K-casein, releasing a hydrophilic MP. The MP can be separated readily from the
remainder of the protein {para-K-casein) by virtue of its solubility in trichloroacetic acid
(TCA). The MP is heterogeneous and consists of a series of components with varying
carbohydrate composition and consequently, a varying solubility in TCA solution (6).
Only the carbohydrate-rich MP (about one-third of the total) is soluble in TCA of
sufficiently high concentration to give complete protein precipitation ( 10-15%) (46, 53,
70).
MP soluble in 2% TCA released by proteases, measured as nonprotein nitrogen,
(NPN-2) reflects the total MP released, whereas the increase ofNPN soluble in 12% TCA
(NPN-12) is a measure of glycomacropeptide (GMP) (46). The difference between
NPN -2 and NPN-12 is an indication of non-glycomacropeptide concentration. Although
this may not be true in all cases, because some fractions ofK-casein have varying
solubility in TCA depending on the carbohydrate content (16, 40). The solubility ofGMP
in TCA depends on the charge and carbohydrate content. The more negatively-charged or
carbohydrate-rich are better soluble in TCA {70).

Amino Acid Composition of Macropeptide
MP is the C-terminal fragment ofK-casein. Amino acid composition of the MP was
reported in 19 57 (45). It contains all the carbohydrate originally present in K-casein.
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Pujolle et al. (54) studied the amino residues released by carboxypeptidase. They
suggested the common C-terminal sequence Thr-Ile-Asn-Val-Thr-Gln-Ser-Val-Thr-AlaValOH. Joiles et al. (30) reported theN-terminal octadecapeptide of 1<-casein MP:
Met-Ala-Ile-Pro-Pro-Lys-Lys-Asn-(Asx, Glx)-Lys-Thr-Glu-(Pro, Ile)-(Asn,Thr, lie).
MP released from 1<-casein variant B is a single polypeptide chain of molecular weight
6, 755 daltons. It consists of 64 amino acids residues (1 Asp, 3 Asn, 11 Thr, 5 Ser,
1 SerP, 8 Glu, 2 Gin, 8 Pro, 1 Gly, 6 Ala, 6 Val, 1 Met, 7 lie, 1 Leu, 3 Lys) and is low
in sulfur amino acids and devoid of aromatic amino acids (Phe, Tyr, and Trp), His, and
Arg (30 , 31, 43, 44, 45). MP contains many hydroxyl amino acid residues. One in four
of the total residues is Thr or Ser (this proportion rises to one in three in the 12-64 region).
According to Hill et al. (26) this may be responsible for the micelle-stabilizing property of
1<-casein. There is a higher number of acidic than basic residues and the negative net
charge of the molecule has been estimated to be 7.5 at pH 6.8. However, because the
average hydrophobicity ofMP is 1,083 (Bigelow's parameter) it can also be considered to
be hydrophobic (45). The high amount (12.5%) and uniform distribution of Pro residues
suggest that the MP has limited structural-coiling possibilities.
The single phosphate group located in MP is linked to Seq49. The MP contains three
of the nine Lys residue of the parent protein. The ratios of total amino groups and
a-amino groups in 1<-casein relative to those in the MP are 2.5 and 1.0 if theN-terminal in
the former is not blocked (11). Vreeman et al. (76) reported that one molecule ofK-casein
can have two phosphates one at Seq49 and the other at Sef127· They suggested that the
phosphate content might also be a cause of the heterogeneity of 1<-casein.
Bovine GMP consists up to 30% carbohydrate, 70% peptide, and .4% phosphorus. It
has molecular weight of6,000-8,000 daltons. MP contains all the carbohydrate originally
present inK-casein. The carbohydrate portion is made up of galactose, galactosamine and
sialic acid. Hill et al. (26) showed that the two amino acid replacements differentiating the
two known genetic variants of 1<-casein are located in the MP. This was confirmed when
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the para-K-casein from genetic variant A and B where found to be identical. GMP can be
separated into at least three well-defmed components that have similar amino acid
composition (39). Thus most of the variation inK-casein is found to occur in the MP
region. Kim (34) pointed out that the observed heterogeneity of the MP is mainly due to
variations in the quantitative sugar composition of the fractions.
Carbohydrate Moiety of Macropeptide
There are two forms of K-casein, one form containing varying amounts of
carbohydrate moiety and the other form devoid of carbohydrate. Both forms of K-casein
coexist in normal milk (46). All the carbohydrate is located in the MP section of the
1<-casein polypeptide. Carbohydrate is linked to the hydroxy amino acid residues of
section 127-141 of the 1<-casein polypeptide chain (32, 45).
Much research has been conducted to elucidate the carbohydrate composition, location
and synthesis in 1<-casein macropeptide (11, 21, 23, 33, 58, 69, 86). The carbohydrate
chains of 1<-casein are synthesized by the successive action of the glycosyl transferases:
UDP-N -acetylgalactosamine; K-casein polypeptide N-acetylgalactosaminyltransferase,
UDP-galactose; asialoagalacto 1<-casein galactosy transferase, and CMP-sialic acid: asialo
1<-casein sialyl transferase in the golgi apparatus of the mammary gland. N-acetylgalactosaminyl transferase catalyzes the first step of glycosylation and is responsible for the
heterogeneity of K-casein ( 65). The carbohydrate sequence of the main sugar portion from
bovine K-casein is indicated to beN -acetylneuraminyl-galactosyl-N -acetylgalactose- amine
(32) . The carbohydrate chain of1<-casein is linked O.glycosidically to the peptide chain.
Alais and Jolles (3) showed that NeuAc, galactose and galactosamine are the only
sugars in bovine GMP. The MP fraction derived from the carbohydrate rich monomer of
K-casein contains up to 30% carbohydrate and is soluble in 12% TCA (6). The
carbohydrate chain ofK-casein was composed ofNeuAc, D-galactose and GalNAc (33) .
Tran and Baker ( 6 7) showed that the carbohydrate moiety of K-casein consists of
trisaccharide units. It may be presented as N-acetylneur-aminyl-(2---+6)-~- galactosyl-
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( 1---+ 3 or 6)-N -acetylgalactoamine. These units are attached to the peptide chain through
the hydroxy groups of Ser or Thr.
Recently, H-NMR spectroscopy was used to determine the structure of the
carbohydrate chains of the three major oligosaccharide alditols obtained from bovine
K-casein GMP after alkaline borohydride reductive cleavage. This study showed the
structure of the carbohydrate as tri- and tetra-saccharide units ofNeuAc, hexose (usually
galactose) and N-acetylhexosamine (usuallyGalNAc). Examples ofthese are
NeuAca(2-+3)GalB( 1-+3)GalNAcB1-Thr/Ser, GalB( 1---+ 3)[Neu-Aca(2-+6)]GalNAc01 Thr/Ser and NeuAca(2-+ 3)Gal0(1-+3)[NeuAca (2-6)]Gal-NAcB1-Thr/Ser (69). The
carbohydrate units are 0-glycosidically linked to Thr or Ser residues in the region 127-141
of the peptide chain.
In mature milk Fiat et al. (23) detected only one site at Thr131· Kanamori et al. (32,
33) reported that Ser and Thr are the binding sites of carbohydrate moieties. The
carbohydrate moieties are attached to Thr131 , Thr133, Thrus (or Thru6) , and SefJ41 · The
possibility is small that Thr136 is the binding site of the sugar chain because Thru6 of
K-casein B is lie. Also Zevaco and Ribadeau-Dumas (86) found that four Thr residues
(Thr131, Thq33 , Thrus and Thq42) and Seq41 can serve as points of attachment for
GalNAc. An average of one GalNAc group and one phosphate group per peptide chain is
found (20). Consequently, a maximum often NeuAc can be accommodated.
The carbohydrate on colostral K-casein is more complex and variable than in normal
milk. Colostrum K-casein contains almost twice as much carbohydrate as does K-casein
from mature milk with two additional monosaccharides: N-acetylglucosamine (GluNAc)
and fucose (20, 24, 86). New neutral oligosaccharides from bovine colostrum K-casein
were identified and characterized by 500-MHz H-NMR spectroscopy. Their structures are
GaiB(l-+3)GalNAc-ol,Gal0(1- 3)[GlcNAc0(1-6)] GalNAc-ol, GalBO- 3)[Ga1B(1-+4) GlcNAcB(l- 6)]Ga1NAc-ol, GalBO- 3){Fuca(l-+ 3) [GalBO- 4)]GlcNAcB
( 1---+ 6} GalNAc-ol (24 ). The sugar content of MP obtained just after parturition is high
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when compared to the normal mature peptide. The carbohydrate moiety of JC-casein
during the colostral period is characterized by the presence ofGluNAc and fucose which
I

disappear 66 h after calving ( 18). In colostrum K-casein, carbohydrate binding sites have
been found in positions Thr131 , Thr133, Thr135, and Thq42 (21, 23, 86).
The function of the carbohydrate in both human and bovine JC-casein have not been
clarified. The carbohydrate does not play a role in micelle stabilizing properties of
JC-casein because carbohydrate-free and carbohydrate-rich JC-casein components have
similar properties in this respect. The role of the carbohydrate may be to prevent
phosphorylation of more than two hydroxy amino acid residues in JC-casein (45).
Tripeptide sequence Ser/Ihr-X-Glu/SerP (where X is any amino acid) is required for
enzymic phosphorylation of caseins. However, according to this assumption, the
hydroxy amino acid residues Seq27, Thr131, Thq33, Thr135 and Thq4slocated in such
anionic sites of the JC-casein polypeptide chain should be phosphorylated. The lack of
phosphate groups in these potential phosphorylation sites may be explained by the
presence of carbohydrate moiety maldng them inaccessible to phosphoryl kinase. If
K-casein contained five additional phosphate groups, there would be significant changes in
its stabilizing properties. The role of the carbohydrate may be to prevent such an
occurrence (45).
The carbohydrate moiety of JC-casein affects the susceptibility of JC-casein components
to various proteases. Doi et al. (20) have proposed that the carbohydrate function may
also be protection of casein micelles against natural milk proteases (especially against
plasmin). Plasmin hydrolyzes carbohydrate-free K-casein, while JC-casein containing a
high carbohydrate level is resistant. The rate of chymosin attack on JC-casein is also
affected by carbohydrate composition (1). As carbohydrate content increases, the rate of
MP release decreases. Castle and Wheelock (15) suggested that the Km value for this
reaction is partly dependent on the carbohydrate composition of individual JC-casein
molecules. This is thought to be a result of modifications in the region 127-141 of the
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primary structure influencing the susceptibility of the Phe10s-Met106 bond towards
enzymic attack ( 1, 20, 81). Consequently, the occurrence of the carbohydrate on the
peptide chains, and especially the occurrence ofNeuAc, increases the clotting time of
K-casein by chymosin action ( 1). K-casein fractions having the highest carbohydrate
contents give the longest clotting times.
K-casein is heterogeneous, largely because of variations in the carbohydrate content of
the GMP released by chymosin action. The carbohydrate moiety lowers the susceptibility
of K-casein component to chymosin (1, 20, 81).
Phosphorylation of K-casein
Phosphorylation of bovine K-casein occurs on Ser121, and Seq49 and in other
unknown positions (76). Although the number of phosphate groups is almost equal to the
number ofGalNAc groups (about one group perK-casein molecule), the distribution of
phosphate group is different from that of the carbohydrate to K-casein ratio. Seq 49 is
always phosphorylated, and therefore, no phosphate-free K-casein exists, which precludes
a random phosphorylation mechanism . In this case the sites are apparently far from
equivalent, the residence time in the golgi apparatus is long enough to saturate Seq49, but
only partial modification of the other sites occurs during this period. Phosphorylation of
Seq27 inhibits glycosylation in vivo (77). The phosphate content might also be a cause of
the heterogeneity of K-casein.
Importance of Macropeptide
MP has been used to answer many questions related to technological problems in the
dairy industry such as heat stability of milk, and coagulation theory ( 11, 25, 53, 81). The
quantity ofMP released by chymosin in diluted milk at pH 7.0 was used to estimate the
concentration of K-casein in milk. K-casein and MP produced the same yield of
fluorescence per mole when reacted with fluorescamine. Therefore, a doubling of
fluorescence in a solution of K-casein is expected when cleavage of the chymosin-sensitive
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bond is completed (11). Pearce (53) developed a method using fluorescamine to
determine the rate of release of MP in rennet-treated milk. Beeby (11) used the same
principle to follow the enzymic action of rennet on milk and to determine the amount of
K-casein in milk.
Hill and Wake (25) proposed that the stability of casein micelles depends, in part, on
the hydrophilic nature of the MP, which contains a high proportion of Thr and Ser
residues and at least one phosphoryl residue. Holt and Dalgleish (27) proposed that the
micelles are sterically stabilized by the MP chain, which could form a hairy layer on the
surface of casein micelles.
Wheelock (81) studied the effect of heat treatment on the primary phase of chymosin
action . He observed that the release of the peptides which lack carbohydrate is almost
completely inhibited , whereas there is little or no effect on the release of the carbohydratecontaining peptides. He suggested that if a complex is formed between

~-lactoglobulin

and K-casein in whole milk as a result of heating, then it is formed preferentially with the
K-casein which lacks carbohydrates. This demonstrates a potential role for the MP
carbohydrate in heat stability in milk.

Biological and Physiological
Activity of Macropeptide
Type and location of the carbohydrate in bovine and human K-casein has well been
characterized, but their precise function remain elusive. It is known that B ifidobacteria
predominate in the intestinal tracts of breast-fed infants and constitute a so-called bifid us
flora. It is also known that B ifidobacteria inhibits the growth of Escherichia coli and
protects breast-fed infants against gastrointestinal disease. Azuma et al. (9) reported that
bovine GMP and human GMP released by the action of chymosin or bovine pepsin from
K-casein are effective as bifidus growth-promoting factor. Human GMP shows growth promoting activity about four times that of bovine GMP and it enhances the growth of
B ifidobacteria at concentrations as low as 50 ppm.
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Lahav et al. (37) observed that GMP soluble in 12% TCA has an inhibitory action
against lactic acid bacteria and Staphylococcus aureus. Lactic acid production is reduced
by 10-23% when GMP is added to skim milk at a level equal to their natural concentration
in enzyme-coagulated milk. The bacterial inhibitory action of the basic GMP released
from heated milk is confirmed by their activity of varying degree against five strains of
S. aureus as test organism. They suggested that heat treatment of milk (80°C) before its
souring in the cheese making process enhances antibacterial action, alters the K-casein and
may be harmful to the process. Ito et al. (28) reported that K-casein retarded the growth of

Lactobacillus bulgaricus and Lactobacillus casei whereas it shows no effect on the growth
of Streptococuss lactis and promoted the growth of Streptococcus thermophilus. Neeser
(51) found that K-casein macropeptide solution (1 mg/ml) inhibited the adhesion of

Streptococcus sanguis, Streptococcus mutans and Actinomyces visosus to plastic tubes.
He concluded that MP can be used as a dental plaque and dental caries inhibiting agent.
Whole casein seems to stimulate either biosynthesis or secretion of chymosin in the
preruminant calf vell since chymosin is the main enzyme responsible for release of MP
from K-casein in the calf abomasum. The MP or one of its fragments may be involv ed in
stimulation of the cells producing chymosin (43 ).
Cherinkov et al. (17), Stan and Cherinkov (60), and Vasilevskaya (72) found that
GMP isolated from whole casein inhibits gastric secretion in dogs. The GMP's antigastrin
activity is similar to that of enterogastrone. They observed that this glycopeptide may be
absorbed from the intestinal cavity into the blood, and may exert an inhibitory effect on
gastric secretion. It is assumed that the enterogastrone may genetically duplicate a slower,
genetically conditioned maturing of the stomach's secretory activity throughout the
postnatal period of development. Aleinik (4) reported that MP decreases basal secretion of
HCl by 50%. In another study Aleinik et al. (5) studied the effect of the MP on gastric
secretion in rats. They observed that acid secretion decreases by 51% in the rat isolated
stomach and gastrin level decreases by 8.3% in the blood serum after intraluminal
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administration of the peptides. Thus, MP may be useful for treatment of gastroduodenal
disorders caused by hyperacidity (62). The physiological effect of MP is apparently
related to regulation of satiation ( 61, 63 ).
An in vivo study was conducted by Yvon and Pelissier (85) to follow casein
hydrolysis inside the stomach of the calf. They found that during the first phase of
digestion (0-90 min) the main peptide released from casein is fragment 106-169 of
K-casein. Thus, MP is almost the only peptide to be released during the first hour (85).
They concluded that the role of the stomach, in addition to regulation of the release of milk
proteins, is to select peptides that enter the gut. Indeed, it could be inferred that peptides
released early in the duodenum might have physiological functions such as regulation of
gastric and pancreatic secretion (4, 5, 17, 60, 61, 62) or an opioid activity (84 ). MP could
be involved in liberation of gastrointestinal hormones, secretine, and somatostatine .
Consequently, secretion of pancreatic proteinases would be maintained for a certain time at
a low level. Then it is possible that the whey proteins that leave the stomach quickly (85)
are not hydrolyzed by pancreatic proteinases and could play a role in the establishment of
the intestinal flora and the immunity of the young. These facts suggest that casein might
have physiological importance besides its nutritional value.
The type of sialydated oligosaccharides in human and cows milk have been identified ,
but their specific functions remain unknown. Most of the oligosaccharides are attached to
K-casein, but some of the sialydated glycoprotein must be secretory IgA, which has a
function in protection of the gastrointestinal tract of the newborn. Secretory IgA has a
relatively high content (10-15%) of bound carbohydrate similar to that on K-casein such as
GalNAc, NeuAc, L-fucose and D-glucose (71, 79).
Amounts of NeuAc-oligosaccharides have been reported to be 120 mg!liter in pooled,
mature human milk and 1400 mg!liter in the milk of a single woman on the first day of
lactation (13) . The amount of sialydated oligosaccharides and glycoproteins available to
infants fed human milk in the first months of life is large, and their function intriguing
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considering the number of developmental changes occurring in early infancy in the brain
as well as in other organs and tissues. Daily intake ofNeuAc from oligosaccharides alone
would be 170 mglkg/d in the first two weeks oflactation, this declines to 20 mglkg/d
beyond ten weeks oflactation. This accounts for .1% (wtlvol) of the diet of exclusively
breast-fed infants in the first two weeks. Milk oligosaccharide and glycoprotein decline
exponentially over the first two months oflactation. Cows' milk, on the other hand,
contains only about 3 mglliter, and the chemical composition ofNeuAc in cows' milk
differs from that ofhuman milk (13). Cows milk and formulas derived from it have
consistently lower concentrations ofNeuAc in the form of oligosaccharides than does
human milk. Formulas made with a whey/casein ratio of 60/40 have higher (72 mg
NeuAdliter) than expected oligosaccharide NeuAc compared to cows' milk and formulas
with whey/casein ratio of 1&/82 (14 mg NeuAdliter). There are not conclusive
experiments to demonstrate that NeuAc is hydrolyzed from milk from these compounds
prior to adsorption . It seems reasonable to suppose that GMP will be acting as
oligosaccharide carrier and is resistant to enzymes in the newborn stomach. GMP could
carry the oligosaccharides to the small intestines where it could be absorbed as is or
hydrolyzed by enzymes. NeuAc could become available as a substrate for sialydation of
gangliosides and brain glycoproteins as well as others organs and tissues (13, 14, 47, 48,

50).
Gangliosides are thought to play an important role as membrane receptor cell surface
markers and in neural transmission. The concentration of gangliosides continuously
increases from the youngest age and reach the adult level as early as the age of two years.
jl
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NeuAc is a constituent of gangliosides and glycoprotein located primarily in the neuronal
membrane (4 7). It contains negative charges and consequent ability to influence the flow
of positive charge moieties. NeuAc is postulated to be the receptor for neurotransmitters
in the central nervous system. Neurotransmitters are positively charged. The negative
charge associated with NeuAc may be involved in binding neurotransmitters to neuronal
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membrane (48, 49, 50). These suggestions conclude that NeuAc forms an integral part of
the containing membrane of neurotransmitter vesicles.
Mammalian species, including human, have the capacity to synthesize NeuAc from
simple sugar precursors and the metabolic intermediate phosphenolpyruvate, but there is
conclusive evidence that exogenously administered NeuAc serves as substrate for
sialydation of glycolipids and glycoproteins in brain cerebral and cerebellar fractions ( 13,
4 7, 48). Exogenous administration of free NeuAc by both oral and Intraperitoneal routes
during accelerated brain gangliosides formation in rats produces a significant increase
{by 13-19%) in the concentration ofNeuAc in brain cerebral and cerebellar gangliosides
and glycoproteins and improves behavioral performance. NeuAc concentration in
gangliosides and glycoproteins is associated with desirable early and long term
modification and improvement ofbehavior in rats (13, 47, 48). NeuAc administration
produces long term changes in behavior in rats that remain through adulthood. At 24
weeks of age treated rats learn theY maze significantly quicker than controls do {13, 48).
The carbohydrate may also be involved in bone and cartilage composition. Rasmussen
and Bordier {55) reported that mucopolysaccharides (contain glucosamine and
galactosamine) are the predominant organic components of cartilage which serve as
nucleation sites for mineral ions.
Peptidic digest of bovine 1<-casein is proved to be an opioid antagonist. The peptide
is named casoxin {84). Casoxin is an opioid antagonist selective for the )..l-and
K-receptors. Also, Stan and Zhuravlev (63) showed that MP hydrolyzate has an opiumlike activity. They mentioned that these hydrolyzates are capable of reducing respiration
and heart rates in rabbits, manifesting opioid and neurotropic actions.
K-casein Macropeptide of Different Species
Recently the primary structure of human GMP was elucidated by Fiat et al. (23).
The carbohydrate portion of GMP consists of fucose, galactose, GluNAc, GlaNAc and
NeuAc. Azuma et al. (8) and Fiat et al. (23) reported that human K-casein contains
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carbohydrate amounting to about 40%-60% of the total weight, which is remarkably
different from bovine K-casein (3%). In both human and bovine GMP some of the
carbohydrate residues are joined to the peptide by 0-glycosidic links with Thr and Ser.
The most extensive differences, however, are in the nonpeptide portion. This forms
more than half of the human GMP molecule when prepared from whole human casein
but only one tenth of cow GMP. The presence of fucose and glucosamine (as well as
galactose and galactosamine) in the human GMP is significant because neither of these is
present in bovine GMP (42).
The amino acid sequences of the MP from seven species (cow, zebu, water buffalo,
goat, ewe, sow and woman) have been compared (43) and the differences are given in
Table 1. The amino acid composition of human GMP differs from bovine GMP in that it
has less Asp, Ser and Lys residues, and the absence ofGly, Leu and Met residues (42).
The middle and the carboxy-terminal regions ofMP have a variable sequence whereas the
N-terminal as well as the C-terminal portion ofpara-K-casein are remarkably similar in the
species studied.
The MP of the seven species could be classified in two groups. Group 1 is
characterized by a higher content of dicarboxylic amino acids, a relatively low average
hydrophobicity, and low carbohydrate content. Bovine, zebu, water buffalo, ovine and
caprine MP fall into this group. Members of group 2 (porcine and human MP) contain
more Pro but less dicarboxylic amino acids and have a much higher average
hydrophobicity and carbohydrate content. Despite the differences observed between the
amino acid sequences, the MPs of the different species present some common features
(43). They are relatively rich in Pro (9-17%) and dicarboxylic amino acids {11-16%) and
their content in hydroxy amino acids is very high (21-30%). Dicarboxylic amino acids
together with hydroxy amino acids linked to either carbohydrate moieties including sialic
acid or phosphate groups are responsible for the high negative charge of the MP. The
conservation of the acidic character of the MP during the course of evolution suggests that
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Table 1. The percent difference* between amino acids sequence of
macropeptides from seven species (43).
(1)

(2) (3) (4) (5) (6)

(!)Human

0

(2) Pig

39

0

(3) Sheep

43

37

0

(4) Goat

45

38

5

0

(5) Buffalo

43

38 23

21

0

(6) Cow, Zebu

45

45 27

29

16

0

*Percent difference for each pair of amino acid sequences times the ratio of the
number of positions containing different amino acid residues to the total
number of positions compared
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electrical repulsive forces play a major role in the stabilizing properties of 1<-casein ( 43).
The study of glycopeptides obtained after enzymic digestion of the human GMP
demonstrates the presence of several prosthetic sugar groups (up to 10) distributed
throughout the peptide chain (23). Human 1<-casein contains about 40% carbohydrate
( 15% galactose, 3% fucose 15% hexosamines, and 5% sialic acid) and .1% (moVmol)
phosphorus (23, 32, 83). The carbohydrate chains from human 1<-casein are characterized
particularly by the presence of a fucose residues, which have never been observed in
1<-casein from another mature milk (58). Its amino acid composition is similar to that of
bovine except for Ser, Glu and Lys contents which are less in human milk (83). The
carbohydrate content and composition ofhuman K-casein are different from those of
bovine 1<-casein. The content in human 1<-casein is much higher than that in bovine
1<-casein. Besides, the carbohydrate consists of fucose, galactose, GalNAc, GluNAc, and
sialic acid, in contrast to bovine 1<-casein which contains only galactose, NeuAc, and
GalNAc (8 , 83).
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PART 2: CHARACTERISTICS OF MACROPEPTIDES ISOLATED
FROM WHOLE CASEIN AND PURE 1e-CASEIN
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ABSTRACT
Macropeptides were isolated from whole casein solution (2.5%) after incubation with
crystalline chyrnosin (EC 3.4.23.4). Trichloroacetic acid (final concentrations 2, 8 and
12%) was added to precipitate protein and inactivate the enzyme after 5, 30 and 60 min
incubation time. Protein precipitate was removed by filtration and the filtrate exhaustively
dialyzed against distilled water to remove trichloroacetic acid and other small molecules.
The dialyzate was then lyophilized and stored at -20"C until required for further use.
These macropeptides were compared using reverse phase high performance liquid
chromatography with macropeptides isolated from 1<-casein.
INTRODUCTION
At normal milk pH, chyrnosin (EC 3.4.23.4) cleaves a specific peptide bond in
1<-casein (Phe10s-Met1o6). The hydrolytic products of this reaction are para-1<-casein and
a hydrophilic macropeptide (MP) fraction.
This MP fraction is heterogeneous. Attached to its peptide chain are a series of
carbohydrates made up oftri- and tetra-saccharide units ofN-acetylneuraminic acid
(NeuAc), hexoses (usually galactose) and N-acetylhexosamines (usually GalNAc). An
example of these are NeuAca(2-+ 3)Gal~(l- 3)GalNAq31-Thr/Ser,

Gal~(l- 3)[Neu-

Aca(2-+ 6)]GalNAc~l-Thr/Ser and NeuAca(2-+3)Gal~(l- 3)[NeuAca(2-+ 6)]GalNAc~ 1-Thr/Ser (28).

The carbohydrate units are O.glycosidically linked to Thr or Ser

residues in the region 127-141 of the peptide chain (15, 27, 28). This difference in
carbohydrate composition is responsible not only for the heterogeneity ofMP but also for
its varying solubility in trichloroacetic acid (TCA) solutions (16, 18).
MP soluble in 2% TCA, measured as nonprotein nitrogen (NPN-2) reflects the total
MP whereas the increase of nonprotein nitrogen soluble in 12% TCA (NPN-12) is a
measure ofMP that contains carbohydrates and is called glycomacropeptide (GMP) (2,
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10, 21, 29). The difference between NPN-2 and NPN-12 is an indication ofnon-glycomacropeptide concentration (7).
There are many functions ofMP. It is responsible for the micelle-stabilizing property
of K-casein and its removal results in coagulation of casein micelles and cheese curd
formation (19, 20).
MP contains ail the carbohydrate present inK-casein (12, 13, 14). There have been
many roles suggested for the presence of this carbohydrate. These include: preventing
phosphorylation of more than two hydroxy amino acid residues inK-casein (20), and
protecting casein micelle stability against natural milk prot eases such as plasmin ( 1, 9).
The quantity ofMP released by chymosin has been used to estimate K-casein concentration
in milk (5). Release ofMP is also used to foiiow the enzymic action of chymosin in milk
(23 ). Its presence in skim milk powder is an indication of adulteration with sweet whey
solids (22).
MP has many biological and physiological functions. It stimulates the calf abomasum
ceiis that produce chymosin (10). MP is also effective as a bifidus growth-promoting
factor. Bifidobacteria help protect breast- fed infants against gastrointestinal disease by
inhibiting the growth of Escherichia coli(3, 4). When MP is injected into dogs, it inhibits
their gastric secretion (6, 26, 30). This may help explain how consuming milk reduces
stomach acidity, in addition to its high buffering capacity. MP also has an inhibitory
action against lactic acid bacteria and Staphylococcus aureus ( 17).
The objectives of this study were to compare TCA fractionation methods for isolating
the MP fraction from casein using reverse phase high performance liquid chromatography
(RP-HPLC), and to isolate a homogeneous variant ofMP from purified K-casein.
MATERIALS AND METHODS
Skim milk was supplied from the Utah State University dairy plant at Logan, Utah.
Crystalline chymosin was obtained from Sigma (Sigma Chemical Company, P.O. Box
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14508, St. Louis, MO 63178). Acetonitrile was obtained from VWR Scientific ( 1737
South Redwood, Salt Lake City , UT 84104 ). All other chemicals were of reagent grade.

Preparation of Whole Casein
Whole casein was precipitated at 2o·c from fresh unpasteurized skim milk by slow
addition of 1.0 N HCl to a final pH 4.6. Casein was separated by filtration through
cheese cloth followed by washing of the precipitate with distilled water then dissolved
back into solution by slow addition of 1.0 N NaOH to a final pH 7.0. This procedure
was repeated three times and the solution of casein at pH 7.0 was lyophilized and stored at
-2o·c.

Purification of lC-casein
Crude K-casein was prepared by the Zittle and Custer method (31 ), excluding the final
ethanol treatment. K-casein was prepared by the Rose et al. method (25) and then
fractionated on DEAE-cellulose by the Davies and Law method (8). Whatman DE52 was
packed in column K50/60 (Pharmacia, Fine Chemicals AB, Uppsala, Sweden). For
chromatography, 100 ml K-casein solution, containing about 5 g was applied to the
column and eluted with 250 ml chromatographic buffer, followed by a linearly-increasing
concentration gradient of NaCl (.03-.052 M).

Preparation of Macropeptide
from Whole Casein
Crystalline chymosin (Sigma Chemical Company, P.O. Box 14508, St. Louis , MO
63178) (1 mg/1 ml) was added to a buffered solution (.05 M phosphate buffer) of casein
(2.5%, pH 6.5). After incubation at 3TC for different times (5, 30 and 60 min), enough
48% TCA was added to give a final TCA concentration of 2, 8 or 12% to precipitate
proteins other than MP and to inactivate the enzyme. The mixture was separated by
filtration through a .2 pm membrane (Gelman Sciences Inc.). The filtrate was then
exhaustively dialyzed (3500 molecular wt cut off) against distilled water at 4•c for 3d to
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remove TCA, and small peptides and other salts. The dialyzate was lyophilized and stored
at -2o·c.

Preparation of Macropeptide
from Purified x:-casein
MP was prepared from purified K-casein solution (.5%, pH 6.5) using the above
procedure except a final concentration of 8% TCA and 15 min incubation time were used
(Scheme 1).

Scheme 1

Purified K-casein
Crystalline ch
Macropeptide+ Para-K-casein
TCA (8%)
Macropeptide + TCA

Macro e tide

Gel-Electrophoresis
Polyacrylamide gel electrophoresis (PAGE) was used to monitor purity of the K-casein
fractions and to confirm their homogeneity. The procedure used was similar to that
reported by Hames (11). Coomassie brilliant blue R-250 (Bio-Rad Laboratories, 1414
Richmond, CA 94804) was used as the staining reagent.

Reversed Phase HPLC
The HPLC equipment used consisted of the following Beckman Instruments, Inc.
(Palo Alto , CA 94304) equipment: two modelllO A solvent delivery systems, a 210 A
injector, a model420 system controller, a model164 variable wavelength detector and
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model427 integrator. All separations were at room temperature on a reverse phase Ultra
Phore C3 column. The flow rate was 1 mVmin, and eluted peptides were detected at 210
nm. The analytical procedure was that described by Pearce (24) with slight modification.
The column was equilibrated with the starting solvent containing 50% acetonitrile (aq) and

.15M NaC1 acidified to pH 2.1 with 1.0 N HCl (Solvent B). For each analysis, 20 ).11 of
the reaction mixture were injected onto the column. A linear solvent gradient program was
used to change the proportion of solvent B ( 100% acetonitrile) going from 0---+ 36% at
0-+ 3 min, from 36-+48% at 3-+ 20 min, and from 48-+ 100% at 20-+ 23 min, and then
back from 100---+0% at 26-+ 30 min.
Amino Acid Analysis
Amino acid analyses were done using a 630017000 amino acid analyzer (Beckman
Instruments, Inc., Palo Alto, CA 94304) after acid hydrolysis of the purified K-casein and
the isolated MP (5 mglml) in 6.0 N HCl for 22 hat 11o·c in evacuated sealed tubes.

RESULTS AND DISCUSSIONS
Purification of lC-casein
The efficiency of the purification steps ofDavies and Law method for isolating
K-casein is given in Figure 1. The eluted materials (D-+ H) were subjected to PAGE and
compared to commercial K-casein (A), whole casein (B) and crude K-casein from the Zittle
and Custer method (C). It was observed that fraction (D) contained all K-casein variants,
while fractions G and H contained different homogeneous types of K-casein. The
conclusion can be drawn from these electrophoretic patterns that a homogeneous variant of
K-casein can be fractionated from complex K-casein by ion exchange chromatography
using linear gradient solvent system described in this paper. The Amino acid profile of the
purified sample (band H) suggests that it is K-casein A.

Figure 1. PAGE of various casein preparations: CommercialK-casein
(A). Whole casein prepared from skim milk by double acid
precipitation (B). 1<-casein prepared by the Zittle and Custer
method (C). 1<-casein prepared by the Davies and Law
method (D, E, F, G and H).
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Action of Chymosin on lC-casein:
Effect of Incubation Time
To determine the best incubation time, K-casein was incubated (at 37"C) with
chymosin for different times. In the first 30 min only two peaks were obtained
representing MP and para-1<-casein (Figure 2). After 30 min the number of peaks
increased indicating that the enzyme starts to randomly cleave other peptide bonds in
both para-1<-casein and MP which thus contributes to contamination of the MP.
Fractionation Methods of Macropeptide
A homogeneous variant ofMP was isolated from K-casein (Figure 3) provided only
one variant of K-casein was used as the source material. Results ofRP-HPLC
fractionation ofmacropeptides are shown in Figure 4. In the chromatogram ofMP
isolated from casein using 2% TCA (Figure 4A) the patterns are very similar at each
incubation time (5 , 30 and 60 min) . These peaks show total MP fractions. In Figure 4B
the number of peaks obtained using 8% TCA was less than in Figure 4A. When using
12% TCA, only one major peak was obtained (Figure 4C). MP solubility decreases with
TCA concentration and this agrees with other reported results of experiments with
K-casein (2, 21, 29).
While the number of peaks increases with incubation time, the higher the final
concentration ofTCA, the smaller the number of peaks obtained. The longer the
incubation time the greater the contamination with peptides from the other fractions of
casein.
The different methods of isolating MP from casein or K-casein are compared in Figure
5. Heterogeneous MP contaminated with small peptides is obtained if it is prepared from
whole casein by direct hydrolysis by chymosin, regardless of incubation time or TCA
concentration used. On the other hand, homogeneous MP could be isolated if
homogeneous K-casein is used as the source materiaL

Figure 2. RP-HPLC chromatogram of the reaction mixture of purified K-casein (.5%, pH 6.5) after
incubation with crystalline chymosin (1 mglml) for 5, 30 and 60 min at 3TC.
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Figure 3. RP-HPLC chromatogram of purified 1<-casein (A) and homogeneous MP (B) isolated by
incubating 1<-casein (A) (.5%) with crystalline chymosin (1 mglml) for 15 min at 3TC.

Figure 4. RP-HPLC chromatograms of macropeptides isolated from 2.5 % whole casein solution (pH 6.5)
incubated with crystalline chymosin (1 mg!ml) for varying times (5, 30 and 60 min) at 37"C. MP
isolated from whole casein using 2% TCA (A). MP isolated from whole casein using 8% TCA
(B) . MP isolated from whole casein using 12% TCA (C).
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The purity of MP isolated from a single variant of K-casein was verified using amino
acid analyses. MP is devoid of His, Arg and the aromatic amino acids (Phe, Tyr, and
Trp) (13). Presence of these amino acids in aMP preparation is a clear indication of
contamination with small peptides from other fractions of caseins. These amino acids
were absent in the MP isolated from K-casein but present when MP was isolated directly
from whole casein (Figure 6). This emphasizes that a homogeneous variant of MP can
only be isolated if homogeneous K-casein is used as source material.

CONCLUSIONS
Macropeptide directly isolated from casein is heterogeneous and frequently
contaminated with small peptides from the other caseins. This occurs no matter what
concentration of TCA or enzyme incubation time is used. It is, however, possible to
isolate a homogeneous MP from K-casein if a homogeneous variant of K-casein is used as
source material.

Figure 6. Chromatograms of the amino acids ofmacropeptides
isolated from whole casein (A), and a purified K-casein (B).
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ENZYMES ON K-CASEIN
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ABSTRACT
The proteolytic activity of some milk-clotting enzymes (chymosin, Mucor miehei
rennet, and Endothia pamsitica rennet) on K-casein was foiiowed by using reverse phase
high performance liquid chromatography. Enzymes were standardized to the same milkclotting activity. The enzymes were incubated with K-casein solution at 3TC for various
incubations time (1, 5, 15, 30 and 60 min). The reactions were stopped by addition of 8
Murea containing 10- 5 Mpepstatin. The chromatograms ofhydrolysis products using the
different enzymes were compared.

INTRODUCTION
K-casein is one of the main components of bovine casein. It is the key to the stability
of casein micelles (24) and essential in preventing as- and ~-caseins from precipitating in
the presence of calcium ions. The first step in milk coagulation is cleavage of a specific
bond on K-casein by milk-clotting enzymes. This limited proteolysis leads to
destabilization of the casein micelles and triggers their aggregation ( 16, 20, 23). Limited
hydrolysis of K-casein by the enzyme chymosin, to release K-casein macropeptide (MP)
(residues 106-169), initiates the coagulation of para-casein micelles to eventually form
curds which are processed to make cheese. Para-K-casein (residues 1-105 of K-casein)
remains as part of the micelles.
Milk-clotting enzymes differ in the rates at which they continue to hydrolyze casein.
Only those enzymes which have high ratios of milk-clotting activity at the pH of milk to
general proteolytic activity under the conditions of cheese ripening are considered suitable
for cheese making.
Much research has been conducted to elucidate the action of milk-clotting enzymes on
K-casein (1, 3, 4, 6, 7, 10, 11 , 12, 13, 21, 22). Different methods have been developed
to follow the action of these enzymes. The classical method for monitoring the enzymic
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steps of milk coagulation uses precipitation of protein with trichloroacetic acid (TCA) and
determination ofKjeldahl nitrogen in the TCA-soluble fraction defined as nonproteinnitrogen (NPN) (2). This procedure can be criticized because a number of unidentified
bonds in the substrate (whole casein or K-casein) are hydrolyzed (8). These may be
different bonds when different enzymes are used. High blank values are obtained when
this method is used with milk because of the nitrogen-containing compound (such as urea)
present in milk (9, 17). Other methods of monitoring the release ofMP include
determination of the sialic acid content ofTCA filtrates (24) and measurement of the
turbidity ofMP suspensions formed by adding phosphotungstic acid to TCA filtrates ( 17).
The objectives of this investigation were to follow and compare the proteolytic activity
of different concentrations of some milk-clotting enzymes (chymosin, Endothia parasitica
rennet, and Mucor miehei rennet) on K-casein, at pH 6.6 and 37·c, using reverse phase HPLC.
MATERIALS AND METHODS
Skim milk was supplied from the Utah State University dairy plant at Logan, Utah.
Crystalline chymosin (EC 3.4.23.4) and pepstatin were purchased from Sigma (Sigma
Chemical Company, P.O. Box 14508, St. Louis, MO 63178). Acetonitrile (HPLC grade)
was obtained from VWR Scientific ( 1737 South Redwood, Salt Lake City, UT 84104 ).
All other chemicals were of reagent grade.
Preparation of Whole Casein
Whole casein was precipitated at 2o·c from fresh unpasteurized skim milk by slow
addition of 1.0 N HCl to a final pH 4.6. Casein was separated by filtration through
cheese cloth followed by washing of the precipitate with distilled water then dissolved
back into solution by slow addition of 1.0 N NaOH to a final pH 7.0. This procedure was
repeated three times and the solution of casein at pH 7.0 was lyophilized and stored at
-2o·c.
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Purification of K-casein
Crude K-casein was prepared by the Zittle and Custer method (25), excluding the final
ethanol treatment. K-casein was prepared by the Rose et al. method (19) and then
fractionated on DEAE-cellulose by the Davies and Law method (5). Whatman DE52 was
packed in column K50/60 (Pharmacia, Fine Chemicals AB, Uppsala, Sweden). For
chromatography, 100 ml K-casein solution, containing about 5 g was applied to the
column and eluted with 250 ml chromatographic buffer, followed by a linearly-increasing
concentration gradient ofNaCl (.03-.052 M).
Enzymic Degradation of K-casein
Hydrolysis of K-casein by milk-clotting enzymes (chymosin, E. parasitica rennet, and

M. miehei rennet) was performed at 37±l"C in water bath. Aliquots (.5 ml) ofK-casein
solution (pH 6.6 in .05 M phosphate buffer) in separate test tubes were incubated at 37"C
for 5 min. Then 5 )Jl of each enzyme solution, standardized for the same clotting time
using Formagraph method (14), were added to each tube separately. Reaction tubes were
removed at 1, 5, 15, 30, and 60 min and the reaction was stopped by addition of .5 ml 8

M urea containing 1o-5 M pepastatin.
Reversed Phase HPLC
The HPLC equipment used consisted of the following Beckman Instruments, Inc.
(Palo Alto, CA 94304) equipment: two modell10 A solvent delivery systems, a 210 A
injector, a model 420 system controller, a model 164 variable wavelength detector and
model427 integrator. All separations were at room temperature on a reverse phase Ultra
Phore C3 column. The flow rate was 1 mVmin, and eluted peptides were detected at 210
nm. The analytical procedure was that described by Pearce ( 18) with slight modification.
The column was equilibrated with the starting solvent containing 50% acetonitrile (aq) and
.15 MNaCl acidified to pH 2.1 with 1.0 N HCl (Solvent B). For each analysis, 20 }Jl of
the reaction mixture were injected onto the column. A linear solvent gradient program was
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used to change the proportion of solvent B ( 100% acetonitrile) going from 0-+ 36% at
0-+ 3 min, from 36-+ 48% at 3-+ 20 min, and from 48-+ 100% at 20-+ 23 min, and then

back from 100-+0% at 26-+30 min.

RESULTS AND DISCUSSION
Application of the NPN method to follow enzymic action on K-casein has been
criticized since the researcher can not tell how and when the real reaction, liberation of
MP, took place. Detailed interpretation of its results are also difficult because it depends
on substrate purity. The enzyme reaction cannot be specifically controlled, and
degradation products (NPN) can come from K-, a- orB-casein in contaminated products.
On the other hand, when this HPLC procedure was used, we were able to see a better
picture on how these enzymes act on K-casein. This can be achieved simply by comparing
chromatogram of each reaction with the others (Figures 7, 8, 9, 10, 11, and 12). Using
HPLC, it is easier to follow the reaction and at the same time verify substrate purity.
Also, it may be possible to use HPLC to standardize different enzymes and to calculate the
standard rennin unit activity since the primary action of the enzymes using this method can
be followed with precision. Purified K-casein is used as a substrate for this reaction. The
rennin unit could be expressed as the peak area of the MP obtained at a certain reaction
conditions.
Chymosin Action on K-casein
Figures 7 and 8 show chromatograms of chymosin action on K-casein fraction.
Although we used two concentrations of the enzyme (1.46 and 73 rennin unitslml), the
chromatograms for both concentrations were basically the same. At different enzyme
concentrations and different incubation times, we obtained only two peaks. The first peak
represents MP and the second peak represents both K-casein and para-K-casein. The
MP-peak increased slightly with incubation time and stopped r.tfter 30 min incubation.
This confirms that chymosin is specific for the cleavage ofPhe10s-Met1o6 peptide bond on

Figure 7. RP-HPLC chromatogram ofthe hydrolytic products from chymosin's action on 1<-casein at various
incubation times. Reaction mixture contains .5 ml of 1% 1<-casein solution (pH 6.6 in phosphate
buffer .05 M) and 5 1-11 chymosin ( 1.46 rennin unit&"ml).
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Figure 8. RP-HPLC chromatogram of the hydrolytic products from chymosin's action on 1<-casein at various
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1<-casein. We concluded that chymosin is the only enzyme capable of transforming
1<-casein completely to macropeptide and para-1<-casein. Microbial enzymes are not
specific and as a result breakdown para-1<-casein to degradation products.

Mucor miehei rennet Action on lC-casein
Figures 9 and 10 show chromatograms of the action of M. miehei rennet on 1<-casein.
At the start of incubation there was little evidence of any action by M. miehei rennet on
1<-casein. As the reaction progressed its proteolytic activity increased to a level where
K-casein was completely degraded. M . miehei rennet action on 1<-caseir1 starts slowly in
comparison with chymosin, but after 10 min it began cleaving other bonds in
para-1<-casein. Thus, M . miehei rennet is less specific and less active than chymosin at the
beginning of the observation time (til115 min), but at the end of incubation time (60 min)

M. miehei rennet cleaves many different bonds on para-1<-casein, which results in the
appearance of more than seven peaks on both chromatograms. M. miehei rennet is not
specific and , as a result, peptides other than and in addition to MP from 1<-casein were
released. We have confirmed the conclusions of Paquet and Ala is (15) that M . miehei
rennet has a more moderate activity; their action modality is near the chymosin, but are still
not as specific forK-casein as chymosin (15).

Endothia parasitica rennet Action on lC-casein
In incubation with E. parasitica rennet there were three peaks present in
chromatograms throughout the observation period at both concentrations (Figures 11 and
12). This indicates that E. parasitica rennet is more proteolytic and less specific than
chymosin (Figures 7 and 8) but more specific and less proteolytic than M. mieheirennet
(Figures 9 and 10). The initial hydrolysis rate of K-casein by E. parasitica rennet was
much higher than both chymosin and M. miehei rennet. This confirms similar conclusions
put forward by Tam and Whitaker (21) who reported that initial rates of hydrolysis of
caseins by E. parasitica rennet were faster than by bovine pepsin, chymosin or M . miehei
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rennet. They also reported that E. parasitica rennet has a faster initial hydrolysis rate of
K-casein at pH 6.0 than pH 5.5. At pH 6.0 all four enzymes had the fastest initial rates of
hydrolysis on K-casein. E. parasitica rennet had more activity than the other three
enzymes on all substrates at all pH's.
These observations on hydrolysis of K-casein by E. parasitica rennet may explain an
interesting finding by McMahon 1983 {unpublished data, presented at annual meeting of
Institute ofFood Technologist, June 21-25, 1982, Las Vegas). He used the Formagraph
to compare curd firming rates of different milk-clotting enzymes by measuring k20, the
time from the start of gel development until a chart width of 20 mm was obtained (Figure
13). The curd-firming rate of E. parasitica rennet was higher than any other milk-clotting
enzyme used in the study, including chymosin.
When using RP-HPLC, peptides are fractionated according to their hydrophobicity.
The least hydrophobic peptides elute first. E. parasitica rennet initially forms MP (eluted
at 8.6 min retention time) and two peptides with similar hydrophobicity {peaks at 9.8 and
10. 1 min) close to or more than para-K-casein. This is similar to that reported for Iprex
Jacteus rennet {Leu 79 -Ser80 ) ( 11 ). These peptides have more areas for hydrophobic

interaction than para-K-casein. Rapid formation of these pep tides may shorten clotting
time when E. parasitica rennet is used and make the curd firming rate faster {reaches k20
sooner).
The action of chymosin, M. miehei rennet and E. parasitica rennet can be summarized
by looking at the number of pep tides formed from hydrolysis of K-casein and the rate at
which they are formed (Figures 14 and 15). At either low or high concentrations,
chymosin was less proteolytic and more specific than other enzymes because only two
peaks were recorded throughout the entire observation time (30 s-60 min). On the other
hand, hydrolysis by M. miehei rennet initially formed two peaks and then after 5 min
incubation the number of the peaks increased rapidly through the rest of the incubation
time. M. miehei rennet is thus less specific than both chymosin and E. parasitica rennet,

Figure 13. Development of curd firmness in Berridge substrate using various milk-clotting enzymes when
clotting time was standardized to 10 min. EP: E. parasitica rennet. CR: calf rennet. BP: Bovine
pepsin.
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Formagraph, equivalent to 1.46 rennin unitslml).
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Figure 15. Effect of milk-clotting enzymes on the number of peptide fragments formed by hydrolysis of
K-casein at pH 6.6 and 37"C. Reaction contained .5 ml of I% K-casein solution (.05 M
phosphate buffer, pH 6.6) and 5 Ill enzyme solution (standardized to the same clotting time using
Formagraph, equivalent to 73 rennin unitslml).
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which produced three peaks up till 15 min incubation and then one more to the end of the
60 min incubation. E. parasitica rennet is more active, and more proteolytic than
chymosin, but is more specific in cleaving K-casein than M. miehei rennet. In the later
phases of the reaction the differences in the mode of action of the three enzymes were
striking.
Breakdown of K-casein to three peaks was achieved by E. parasitica rennet within the
first minute. With chymosin the two peaks during the first 5 min incubation persisted
throughout the observation period. Non-specific proteolysis of M. mieheirennet started at
10 min and yielded different products after degrading para-K-casein.

CONCLUSIONS
The chromatogram patterns of K-casein treated with chymosin contained two peaks at
the end of the observation period. By this time the chromatogram patterns of K-casein
treated with M. miehei rennet and E. parasitica rennet contained six to seven and four
peaks respectively. The action of theM. miehei rennet on K-casein showed no limitation,
and degradation of para-K-casein continued throughout incubation time. The proteolytic
action involves not only cleavage of a specific bond on K-casein but also a continued
general proteolysis. E. parasitica rennet started directly by cleaving specific bonds in
K-casein and this specificity lasted to the end of the observation time. E. parasitica rennet
is more specific and less proteolytic than M. miehei rennet. Initial rate of hydrolysis of
K-casein with E. parasitica rennet was much higher than both chymosin and M. miehei
rennet.
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PART 4: PROTEOLYTIC ACTIVITY OF SOME PROTEINASES ON
MACROPEPTIDE ISOLATED FROM K-CASEIN
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ABSTRACT
Proteolytic activity of some proteinases (chymosin, bovine pepsin, Mucor miehei
rennet, Endothia parasitica rennet, trypsin and chymotrypsin) on macropeptide isolated
from K-casein was measured. Macropeptide solutions (10 mg macropeptide in 1 ml .05 !11
pH 6.6 phosphate buffer) were incubated with the enzymes at 3TC for various incubation
times. Reactions were stopped by addition of .025 ml pepstatin ( 1 mg pepstatin in I ml
methanol). Reaction mixtures were separated into fractions using reverse phase high
performance liquid chromatography. Macropeptide was resistant to all milk-clotting
enzymes used in this study, including bovine pepsin, when the pH of the macropeptide
solution was adjusted to 6.6. Macropeptide was degraded by bovine pepsin at pH 3.0.
Trypsin and chymotrypsin most readily further degraded the macropeptide. Physiological
functions of the macropeptide are discussed.

INTRODUCTION
Chymosin specifically cleaves the Phews-Met1o6 peptide bond in bovine K-casein.
The hydrolytic products are an insoluble (hydrophobic) para-K-casein and soluble
(hydrophilic) macropeptide (MP). In cheese making, MP is drained with the whey. MP
released from K-casein variant B is a single polypeptide chain of molecular weight 6, 755
daltons. It consists of 64 amino acid residues (1 Asp, 3 Asn, 11 Thr, 5 Ser, 1 SerP,
8 Glu, 2 Gin, 8 Pro, 1 Gly, 6 Ala, 6 Val, I Met, 7 lie, 1 Leu, 3 Lys) and is low in sulfur
amino acids and devoid of aromatic amino acids (Phe, Tyr, and Trp) as well as His, and
Arg (12, 15, 22, 23, 24). Most variations which cause the heterogeneity ofK-casein are
in the MP region and MP contains all the carbohydrate originally present in K-casein.
This carbohydrate is composed ofN-acetylneuraminic acid (NeuAc), D-galactose and
N-acetylgalactosamine (GalNAc) (17). Tran and Baker (37) showed that the carbohydrate
moiety of K-casein consists of trisaccharide units. It may be present as N-acetylneur-
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aminyl(2-76)~-galactosyl

(l--73 or 6)N-acetyl galactosamine. More recently, H-NMR

spectroscopy was used to determine the structure of the carbohydrate chains obtained from
bovine K-casein GMP after reductive cleavage by alkaline borohydride (38). The
carbohydrate structure was determined as tri- and tetra-saccharide units of NeuAc, hexoses
(usually galactose) and N-acetylhexosamines (usually GalNAc).
Carbohydrate is linked to the hydroxy amino acid residues (Thr or Ser) of section
127-141 of the K-casein polypeptide chain (16, 24). Vreeman et al. (41) reported that one
molecule of K-casein can have two phosphates, one at Ser149 and the other at Ser127
which occur in the MP portion . He suggested that the phosphate content might also be a
cause of heterogeneity of K-casein . Hill et al. (10) showed that the two amino acid
replacements ( K-casein B differs from A variant by substitution of Thr for Ile in position
136 and Asp for Ala in position 148) differentiating the two known genetic variants of
K-casein are located in the MP.
The action of milk-clotting enzymes on K-casein has been extensively studied , but the
further breakdown of MP has been less investigated. Recently, Kobayashi et al. (1 8)
studied the specificity of a milk-clotting enzyme from Irpex lacteus on K-casein. They
reported that/. lacteus enzyme hydrolyzes K-casein at the chymosin-sensitive bond of
Phe 105 -Met 106 and also at the positions Leu 79 -Ser 80 and Tyr 30 -Val 31 in the para-K-casein
section. They were unsure how this enzyme acts on the MP fraction of K-casein .
Much research has been conducted to study and explain the function of MP. Many
physiological functions have been suggested. The main peptide released from casein
inside the stomach of the calf is the MP fragment residues 106-169 of K-casein ( 43 ). It
could be inferred that peptides released early in the duodenum might have physiological
functions such as regulation of gastric or pancreatic secretion (1, 2, 6, 33, 34, 35 ). MP
could be involved in the liberation of the gastrointestinal hormones, secretine, and
somatostatine ( 1, 2, 34 ). Its physiological effect is apparently related to regulation of
satiation (34, 36).
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Peptides fragments from K-casein, including the MP, have an opioid function (42).
Homologies have been found between the sequence of bovine K-casein and they-chain of
human fibrinogen. Jolles et al. (14) found that the natural or synthetic undecapeptide
Met-Ala-Ile-Pro-Pro-Lys-Lys-Asn-Gln-Asp-Lys (residues 106-7116 of bovine K-casein)
inhibited both aggregation of ADP-treated platelets and binding of 125J-fibrinogen to
ADP-treated platelets. These facts suggest the physiological importance of MP.
The objective of this study was to investigate the resistance of MP to some
milk-clotting enzymes such as chymosin, bovine pepsin, Endothia parasitica rennet, and
Mucor miehei rennet and to some gastric proteinases (trypsin and chymotrypsin).

MATERIALS AND METHODS
Skim milk was supplied from the Utah State University dairy plant at Logan, Utah .
Crystalline chymosin and pepstatin were purchased from Sigma (Sigma Chemical
Company, P.O. Box 14508 , St. Louis, MO 63178). Acetonitrile HPLC grade was
obtained from VWR Scientific (1737 South Redwood, Salt Lake City, UT 84104) . All
other chemicals were of reagent grade.

Preparation of Whole Casein
Whole casein was precipitated at 2o·c from fresh unpasteurized skim milk by addition
of 1.0 N HCl to a final pH 4.6. Casein was separated by filtration through cheese cloth
followed by washing of the precipitate with distilled water then dissolved back into
solution by slow addition of 1.0 N NaOH to a final pH 7.0. This procedure was repeated
three times and the solution of casein at pH 7.0 was lyophilized and stored at -2o·c.

Purification of x:-casein
Crude K-casein was prepared by the Zittle and Custer method (44), excluding the final
ethanol treatment. K-casein was prepared by the Rose et al. method (32) and then
fractionated on DEAE-cellulose by the Davies and Law method (8). Whatman DE52 was

89
packed in column K50/60 (Pharmacia, Fine Chemicals AB, Uppsala, Sweden). For
chromatography, 100 ml K-casein solution, containing about 5 g was applied to the
column and eluted with 250 ml chromatographic buffer, followed by a linearly-increasing
concentration gradient of NaCl (.03-.052 M).

Preparation of Macropeptide
from lC-casein Component
Crystalline chymosin (Sigma Chemical Company, P.O. Box 14508, St. Louis, MO
63178) (1 mg/1 ml) was added to a buffered solution (.05 M phosphate buffer) of purified
K-casein (1 %, pH 6.5). After incubation at 3TC for 15 min enough 48 % TCA was added
to give a final TCA concentration of 8% to precipitate proteins other than MP and to
inactivate the enzyme. The mixture was separated by filtration through a .2 ).l m membrane
(Gelman Sciences Inc.). The filtrate was then exhaustively dialyzed (3500 molecular wt
cut off) against distilled water at 4•c for 3 d to remove TCA, small peptides and other
salts. The dialyzate was lyophilized and stored at -2o·c.

Enzymic Degradation of lC-casein Macropeptide
Hydrolysis of K-casein macropeptide by milk-clotting enzymes (chymosin, bovine
pepsin, E . parasitica rennet, and M . miehei rennet) and trypsin and chymotrypsin was
performed at 3TC in a thermally controlled water bath. Aliquots (.5 ml) of K-casein
macropeptide solution (pH 6.6 in phosphate buffer .05 M) in separate test tubes were
incubated at 3TC in a water bath for 5 min then 5 ).11 of each enzyme solution,
standardized for the same clotting time using Formagraph method (21), was added to each
tube separately. Reaction tubes were removed at 1, 5, 15, 30, and 60 min and the reaction
was stopped by addition of .025 (1 mg/ml) pepastatin.

Reversed Phase HPLC
The HPLC equipment used consisted of the following Beckman Instruments, Inc.
(Palo Alto , CA 94304) equipment: two model 110 A solvent delivery systems, a 210 A
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injector, a model 420 system controller, a model 164 variable wavelength detector and
model427 integrator. All separations were at room temperature on a reverse phase Ultra
Phore C3 column. The flow rate was 1 mVmin, and eluted peptides were detected at 21 0
run. The analytical procedure was that described by Pearce (31) with slight modification.
The column was equilibrated with the starting solvent containing 50% acetonitrile (aq) and
.15M NaCI acidified to pH 2.1 with 1.0 N HCl (Solvent B). For each analysis, 20 ,ul of
the reaction mixture were injected onto the column. A linear solvent gradient program was
used to change the proportion of solvent B ( 100% acetonitrile) going from 0--+ 36% at
0--+ 3 min, from 36--+ 48% at 3--+ 20 min, and from 48--+ 100% at 20--+ 23 min, and then
back from 100--+0% at 26--+ 30 min.
RESULTS AND DISCUSSION
Several forces are involved in enzyme hydrolysis ofl<:-casein. These include repulsive
forces (such as electrostatic and hydration effect) and attractive forces (such as hydrogen
bonding and hydrophobic interactions) between K-casein and the attaching enzyme.
Chymosin and K-casein have a net negative charge (9), and at low ionic strengths,
electrostatic repulsion occurs between them (30). Low concentration of salt ions ( < 10
rnMCaC1 2) enhance the interaction between chymosin and native K-casein (31). An
important feature of K-casein, however, is the cluster of positively charged residues near
the susceptible peptide bond. There are one Arg, three His and two Lys among the amino
acid residues 97-112 (4, 13). The specificity of chymosin forK-casein is related to the
presence of this cluster of cationic residues.
Hydrophobic interactions are a major driving force for protein-protein interactions.
There are also several hydrophobic amino acids near the chymosin-sensitive bond
(Leu1o3, Phe105, Metio6, Ala107, and IleJOg) which contribute to enzyme-substrate
binding (40). Hydration (association of macromolecule polar groups with water
molecules) causes repulsion between macromolecules as soon as the separation distance is
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of the order of a few water molecules (7). The repulsive hydration force is consequence
of the work needed to remove water from the vicinity of the polar groups.
All these factors that enhance chymosin action on K-casein are non-existent in the MP
fraction. MP is hydrophilic, negatively charged, devoid of aromatic amino acids (Phe,
Tyr, and Trp), rich in acidic and hydroxy amino acids and contains all the carbohydrate
present on K-casein. All these factors increase hydration repulsive forces between MP and
milk-clotting enzymes.
Milk-Clotting Enzymes Action on Macropeptide
Figures 16, 17, and 18 show the chromatograms of the action of chymosin, M. miehei
rennet and E. parasitica rennet on MP isolated from K-casein. In all the chromatograms
shown in Figures 16, 17, and 18 there are only two peaks; the first one represents MP and
the second, pepstatin. All milk-clotting enzymes used in this study have no effect on MP
at the two different concentrations used at any of the incubation times (5, 30, 60 min).
This may be due to the repulsive forces {such as hydration effect and the hydrophilicity of
the MP) between the MP and the enzymes. Figure 19 shows the chromatogram of bovine
pepsin action on MP at two pH's 6.6 (Figure 19A), and 3.0 (Figure 19B). Bovine pepsin
has no effect on MP at pH 6.6, but when the pH of the MP solution was adjusted to 3.0,
the MP was completely degraded to small peptide by bovine pepsin.
Trypsin Action on Macropeptide
Trypsin catalyzes hydrolysis of only those peptide bonds in a polypeptide chain whose
carbonyl function is donated by either a Lys or Arg residue, regardless of the length or
amino acid sequence of the chain (20). The number of peptide fragments resulting from
the action of trypsin can thus be predicted from the total number of Lys and Arg residues
in the peptide chain. MP has no Arg and contains only three Lys adjacent to each other.
Figure 20 shows the chromatogram of trypsin action on MP. As expected, only two
peaks were produced throughout the observation time (5, 15 and 30 min). MP contains

Figure 16. RP-HPLC chromatogram of the hydrolytic products from chymosin's action on MP isolated from
K-casein. Reaction mixture contained .5 ml of 1% MP solution (pH 6.6 in phosphate buffer .05
M) and 5 ).ll chymosin was added at 1.46 rennin units per ml (A) and .5 ml of 1% MP solution

(pH 6.6 in phosphate buffer .05 M) and 5 ).ll chymosin was added at 73 rennin unit&"ml (B).
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Figure 17. RP-HPLC chromatogram of the hydrolytic products from M. miehei rennet's action on MP
isolated from K-casein. Reaction mixture contained .5 ml of 1% MP solution (pH 6.6 in
phosphate buffer .051\1) and 5 111M. miehei rennet was added at 1.46 rennin units per ml (A)
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only three Lys at position 111, 112 and 116 and there are five possible positions for
trypsin to cleave a bond on MP. These points are position Prouo-Lysu1, Lysu1-Lysu2,
Lys112-Asn113, Asp11s-Lys116 and Lysu6-Thr117·
Chymotrypsin Action on Macropeptide
Chymotrypsin can attack short peptides. It can split certain peptide linkage whereve r
they occur in a peptide chain (20). It was thought to be specific for peptide linkage in
which the carbonyl function is contributed by aromatic amino acid residues such as Tyr,
Trp and Phe. It also hydrolyzes the amides of these amino acids. It was also found that
the aromatic rings traditionally thought to be required by chymotrypsin are dispensabl e,
since replacement of the benzene ring of Phe residue with a cyclohexyl ring or other bulky
hydrocarbon group causes little decrease in activity. Furthermore, not even the a-amino
group of the aromatic amino acid is required, since it may be replaced by a hydrogen atom ,
a hydroxyl group, or a chlorine atom (20) . MP is devoid of the aromatic amino acids
including Phe. Chymotrypsin degraded MP to many fragments at pH 6.6 and 3TC
(Fi gure 21).
Biological and Physiological Activity of Macropeptide
There are many physiological functions suggested for the MP. Yvon and Pelissier
(43) followed casein diet hydrolysis inside the stomach of the calf. They showed that
during the first phase of the digestion (0-90 min) the main peptide released from casein
was fragment I 06-169 of K-casein. Thus, MP was almost the only peptide to be released
during the first hour (44). It could be inferred that peptides released early in the
duodenum might have physiological functions such as the regulation of gastric and
pancreatic secretion (1, 2, 6, 32, 33, 34) or an opioid activity (42).
Gastric Secretion. MP could be involved in the liberation of gastrointestinal
hormones, secretine, and somatostatine. Chemikov et al. (6), Stan and Cherinkov (33)
and Vasilevskaya (39) found that GMP isolated from whole casein inhibited gastric

Figure 20. RP-HPLC profile of the hydrolytic products from trypsin's action on MP at pH 6.6 and 37"C.
Reaction mixture contained .5 ml of 1% MP solution (.05 Mphosphate buffer, pH 6.6) and 10
JJl trypsin solution (.0 125 mglml).
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secretion in dogs. The GMP's antigastrin activity is similar to that of enterogastrone.
They observed that this glycopeptide may be absorbed from the intestinal cavity into the
blood, and may exert an inhibitory effect on gastric secretion. Aleinik (1) reported that
MP decreases basal secretion ofHCl by 50%. In another study Aleinik et al. (2) studied
the effect of the MP on gastric secretion in rats. They observed that the acid secretion
decreases after intraluminal administration of the pep tides by 51% in the rat isolated
stomach and gastrin level decreases by 8.3% in the blood serum. Thus, MP may be useful
for the treatment of gastroduodenal disorders caused by hyperacidity (35). The
physiological effect ofMP is apparently related to regulation of satiation (34, 36).
Consequently, secretion of pancreatic proteinases would be maintained for a certain time at
a low level. It is possible that MP and whey proteins that leave the stomach quickly (43)
are resistant to the stomach's enzymes and could play a role in the establishment of the
intestinal flora and the immunity of the young, particularly during the colostral period.
MP could be absorbed intact including the essential carbohydrates attached to it. These
facts suggest that milk protei n including MP might have physiological importance besides
its nutritional value.
Biftdus Growth-Promoting Factor. Azuma et al. (3) reported that bovine GMP and
human GMP released by the action of chymosin or bovine pepsin from K-casein are
effective as bifidus growth-promoting factor. Bifidobacteria inhibits the growth of
Escherichia coli and protects breast- fed infants against gastrointestinal disease.
Inhibitory Action. Lahav et al. ( 19) observed that GMP soluble in 12% TCA has an
inhibitory action against lactic acid bacteria and Staphylococcus aureus. Ito et al. (II)
reported that K-casein retards the growth of Lactobacillus bulgaricus and Lactobacillus
casei whereas it shows no effect on the growth of Streptococuss lactis and promotes the
growth of Streptococcus thermophilus. Neeser (29) found that K-casein macropeptide
solution (1-mglml) inhibits the adhesion of Streptococcus sanguis, Streptococcus mutans
and Actinomyces visosus to plastic tubes. He concluded that MP can be used as a dental
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plaque and dental caries inhibiting agent.
Neurotransmitter Receptors. The carbohydrate present on MP has a different
composition. These carbohydrates differ among species in their quantity and quality. In
human K-casein the carbohydrates are 40-50% of the totalK-casein molecule. In bovine
K-casein these carbohydrates amount to 6-10% only. Their composition is changed during
lactation. Their function in both human and bovine K-casein has not been clarified.
NeuAc-oligosaccharide is postulated to be the receptor for neurotransmitters in the central
nervous system. Neurotransmitters are positively charged; the negative charge associated
with NeuAc may be involved in the process ofbinding neurotransmitters to the neuronal
membrane (26, 27, 28). These suggestions lead to the conclusion that NeuAc forms an
integral part of the containing membrane of neurotransmitter vesicles.
There is evidence that exogenously administered NeuAc serves as substrate for
sialydation of glycolipids and glycoproteins in brain cerebral and cerebellar fractions
(5, 25 , 26). Exogenous administration of free NeuAc by both oral and Intraperitoneal
routes duri ng the period of accelerated brain ganglioside formation in rats produces a
significant increase (by 13-19%) in the concentration ofNeuAc in brain cerebral and
cerebellar gangliosides and glycoproteins and improves behavioral performance. MP
should be therefore, considered as a possible source of biologically active components.
Macropeptide Resistance to Enzymic Degradation
Several researchers have established the importance ofMP as an active biological
component. We assumed that MP would be resistant to various gastric enzymes and
would be absorbed intact into the blood stream. MP may secure its path by controlling
gastric secretion and decreasing secretion ofHCl. In other words, bovine pepsin will not
act actively on the MP if the pH is adjusted close to neutral. This resistance ofMP may
allow it to travel safely through the stomach and deliver essential carbohydrates which are
needed by healthy infants.
The resistance ofMP to these enzymes suggests that since all the carbohydrate present
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inK-casein needs to be carried as a complex safely through the digestive system, MP may
serve as an oligosaccharide carrier. Thus, it could be intactly absorbed into the blood
stream. One of the important roles of MP is to carry the carbohydrate. The carbohydrate
plays an important role by protecting MP from being cleaved by the stomach's enzymes.
There could be two possibilities for the resistance ofMP. The first reason is that
carbohydrate plays a role as protecting agent by covering the MP chain and making it more
hydrophilic and increasing its negative charges which make it difficult for milk-clotting
enzymes to become attached to it. Second, most of the milk-clotting enzymes require
hydrophobic site on K-casein in order to catalyze the reaction. The hydrophilicity and
hydration effect ofMP protected it from being attached to these enzymes by increasing the
repulsive forces between the MP and the milk-clotting enzymes.
CONCLUSIONS
MP is resistant to all milk-clotting enzymes used in this study, including bovine
pepsin, when the pH of the MP solution is adjusted to 6.6. Trypsin and chymotrypsin
degrade the MP to small fragments while bovine pepsin will function only when the pH of
the MP solution is adjusted to 3.0.
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GENERAL SUMMARY
Macropeptide directly isolated from casein is heterogeneous and frequently
contaminated with small peptides from the other caseins. This occurs no matter what
concentration of trichloroacetic acid (TCA) or enzyme incubation time is used. It is,
however, possible to isolate a homogeneous MP from K-casein if a homogeneous variant
of K-casein is used as source material.
Chymosin is the only enzyme capable of transforming K-casein completely to
macropeptide (MP) and para-x-casein. Action of the Mucor miehei rennet on K-casein
showed no limitation, and degradation ofpara-K-casein continued throughout incubation
time. M. miehei rennet is less specific and more proteolytic than chymosin. Edothia
parasitica rennet cleaves specific bonds in x-casein and this specificity lasts to the end of
the observation time. E. parasitica rennet is more proteolytic than chymosin. E. parasitica
rennet is more specific and less proteolytic than M. miehei rennet.
MP is resistant to all milk-clotting enzymes used in this study including bovine pepsin
when the pH of the MP solution is adjusted to 6.6. Trypsin and chymotrypsin degrade the
MP to small fragments, while bovine pepsin will function only when the pH of the MP
solution is adjusted to 3.0.
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